journal article·2010-04

Synthesis of silicate glass/poly(l-lactide) composite scaffolds by freeze-extraction technique: Characterization and in vitro bioactivity evaluation

Abeer M. El-Kady, Ebtsam A. Saad, Bothaina M. Abd El-Hady, Mohmmad M. Farag

Ceramics International· Volume 36· Issue 3
Publisher page

Abstract

Abstract The main objectives of the present study were to fabricate the silicate glass/poly( l -lactide) composite scaffolds for bone engineering applications, by using the freeze-extraction technique, and to evaluate the possibility for optimizing their degradation rate by changing their glass content. The scaffolds characterized by SEM-EDXA, FT-IR, TGA and XRD. Examination of the SEM microphotographs revealed that the pore size of the scaffolds decreased as the glass content increased. The neat polymer scaffold (PLA) had a highly interconnected porous structure with a maximum pore size of 200 μm. For the composite scaffold containing glass content up to 25 wt% (SP25) and up to 50 wt% (SP50), the maximum pore size was 40 μm and 20 μm respectively. The apparent porosity was 56.56%, 52.49% and 48.74% for PLA, SP25 and SP50, respectively. The results of the degradation study showed that the water absorption of the scaffolds decreased by increasing their glass content, It reached finally to 48.71%and 30.93% for SP25 and SP50, respectively. It revealed that also the weight loss of the scaffolds increased by increasing the glass content. The final weight loss was around 5.44%, 9.31% and 26.17% for the PLA, SP25 and SP50, respectively, indicating that it was possible to modulate the degradation rate of the scaffolds by varying their glass content. In addition, the pH measurement of incubation medium indicated that the glass could compensate the acidic degradation products of the polymer. In vitro bioactivity evaluation showed that the composite scaffolds were able to induce the formation of hydroxyapaptite layer on their surfaces, demonstrating their potential application in bone engineering.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Dental materials and restorations · Orthodontics and Dentofacial Orthopedics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (46)

Show source-provided references
1. Born again bone: Tissue engineering for bone repair
2. Biomaterials and scaffolds in reparative medicine10.1111/j.1749-6632.2002.tb03057.x ↗
3. Levenberg · 2004 · vol. 61
4. Emerging design principles in biomaterials and scaffolds for tissue engineering10.1111/j.1749-6632.2002.tb03056.x ↗
5. Porosity of 3D biomaterial scaffolds and osteogenesis10.1016/j.biomaterials.2005.02.002 ↗
6. Biomedical application of functional polymers10.1016/S1381-5148(98)00054-6 ↗
7. 1999
9. Ionic products of bioactive glass dissolution increase proliferation of human osteoblasts and induce insulin-like growth factor II mRNA expression and protein synthesis10.1006/bbrc.2000.3503 ↗
10. Differentiation of fetal osteoblasts and formation of mineralized bone nodules by 45S5 Bioglass® conditioned medium in the absence of osteogenic supplements10.1016/j.biomaterials.2009.03.019 ↗
11. Hench Genetic design of bioactive glass
12. Gene expression profiling of human osteoblasts following treatment with the ionic products of Bioglass 45S5 dissolution10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.0.CO;2-D ↗
13. Osteogenic differentiation of cultured marrow stromal stem cells on the surface of bioactive glass ceramics10.1002/(SICI)1097-4636(199611)32:3<341::AID-JBM6>3.0.CO;2-S ↗
14. Bonding mechanisms at the interface of ceramic prosthetic materials10.1002/jbm.820050611 ↗
15. Comparative bone formation in several kinds of bioceramic granules
16. Porous poly([alpha]- hydroxyacid)/Bioglass(R) composite scaffolds for bone tissue engineering. I. Preparation and in vitro characterization10.1016/j.biomaterials.2003.10.082 ↗
17. Development and in vitro characterization of novel bioresorbable and bioactive composite materials based on polylactide foams and Bioglass® for tissue engineering applications10.1016/S0142-9612(02)00131-X ↗
18. PDLLA/Bioglass® composites for soft-tissue and hard–tissue engineering: an in vitro cell biology assessment10.1016/j.biomaterials.2003.09.081 ↗
19. The effect of bioactive glass content on synthesis and bioactivity of composite poly (lactic-co-glycolic acid)/bioactive glass substrate for tissue engineering10.1016/j.biomaterials.2004.06.027 ↗
20. Mechanical properties of highly porous PDLLA/Bioglass_composite foams as scaffolds for bone tissue engineering10.1016/j.actbio.2005.07.003 ↗
21. Enhanced differentiation and mineralization of human fetal osteoblasts on PDLLA containing Bioglass® composite films in the absence of osteogenic supplements10.1002/jbm.a.30910 ↗
22. Self-reinforced composites of bioabsorbable polymer and bioactive glass with different bioactive glass contents. Part II. In vitro degradation10.1016/j.actbio.2007.06.007 ↗
23. A mesoporous bioactive glass/polycaprolactone composite scaffold and its bioactivity behavior10.1002/jbm.a.31371 ↗
24. Compositional effects on the formation of a calcium phosphate layer and the response of osteoblast-like cells on polymer-bioactive glass composites10.1016/j.biomaterials.2005.04.005 ↗
25. Bioactivity and osteoblast responses of novel biomedical nanocomposites of bioactive glass nanofiber filled poly(lactic acid)10.1002/jbm.a.31339 ↗
26. Preparation and characterisation of poly(lactide-co-glycolide) (PLGA) and PLGA/Bioglass® composite tubular foam scaffolds for tissue engineering applications10.1016/j.msec.2004.03.002 ↗
27. Characterisation of bioactive and resorbable polylactide/Bioglass® composites by FTIR spectroscopic imaging10.1016/j.biomaterials.2003.10.099 ↗
28. Preparation, characterization, and in vitro degradation of bioresorbable and bioactive composites based on Bioglass®-filled polylactide foams10.1002/jbm.a.10587 ↗
29. Preparation of porous scaffolds by using freeze-extraction and freeze-gelation methods10.1016/S0142-9612(03)00483-6 ↗
30. Fabrication and characterization of chitosan/gelatin porous scaffolds with predefined internal microstructures10.1016/j.polymer.2007.05.048 ↗
31. Poly(a-hydroxyl acids)/hydroxyapatite porous composites for bone-tissue engineering, I. Preparation and morphology10.1002/(SICI)1097-4636(19990315)44:4<446::AID-JBM11>3.0.CO;2-F ↗
32. Nucleation and growth of apatite on amorphous phases in simulated body fluid
33. Smith · 2001
34. Effect of polymer foam morphology and density on kinetics of in vitro controlled release of isoniazid from compressed foam matrices10.1002/(SICI)1097-4636(199704)35:1<107::AID-JBM11>3.0.CO;2-G ↗
35. Early stages of calcium phosphate layer formation in bioglasses10.1016/0022-3093(89)90011-2 ↗
36. Kim · J. Biomed. Mater. Res. · 1992 · 26 · 114710.1002/jbm.820260905 ↗
37. Synthesis of polylactic acid–polyglycolic acid blends using microwave radiation
38. Bioactivity of bioresorbable composite based on bioactive glass and poly-L-lactide10.1016/S1003-6326(07)60105-8 ↗
39. Bioresorbable and bioactive polymer/Bioglass® composites with tailored pore structure for tissue engineering applications10.1016/S0266-3538(03)00275-6 ↗
40. Acidity near eroding polylactidepolyglycolide in vitro and in vivo in rabbit tibial bone chambers10.1016/S0142-9612(96)00075-0 ↗
41. pH-stabilization of predegraded PDLLA by an admixture of water-soluable sodiumhydrogenphosphate-results of an in vitro-and in vivo-study10.1016/S0142-9612(02)00046-7 ↗
42. A composites approach to tissue engineering10.1002/9780470294758.ch90 ↗
43. pH-compensation effect of bioactive inorganic fillers on the degradation of PLGA10.1016/j.compscitech.2005.04.051 ↗
44. Stamboulis · J. Mater. Sci. Mater. Med. · 2002 · 13 · 84310.1023/A:1016544211478 ↗
45. Small changes in polymer chemistry have a large effect on the bone–implant interface: evaluation of a series of degradable tyrosinederived polycarbonates in bone defects10.1016/S0142-9612(99)00151-9 ↗
46. In vitro Ca-P precipitation on biodegradable thermoplastic composite of poly(ecaprolactone-codl-lactide) and bioactive glass (S53P4)10.1016/S0142-9612(03)00558-1 ↗